We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Exploring the Mechanical Perspective of a New Anti-Tumor Agent: Melatonin

Abstract & Overview

Melatonin is a serotonin-derived pineal gland hormone with many biological functions like regulating the sleep-wake cycle, circadian rhythm, menstrual cycle, aging, immunity, and antioxidants. Melatonin synthesis and release are more pronounced during the night, whereas exposure to light decreases it. Evidence is mounting in favor of the therapeutic effects of melatonin in cancer prevention, treatment and delayed onset in various cancer subtypes. Melatonin exerts its anticancer effect through modification of its receptors such as melatonin 1 (MT1), melatonin 2 (MT2), and inhibition of cancer cell proliferation, epigenetic alterations (DNA methylation/demethylation, histone acetylation/deacetylation), metastasis, angiogenesis, altered cellular energetics, and immune evasion. Melatonin performs a significant function in immune modulation and enhances innate and cellular immunity. In addition, melatonin has a remarkable impact on epigenetic modulation of gene expression and alters the transcription of genes. As an adjuvant to cancer therapies, it acts by decreasing the side effects and boosting the therapeutic effects of chemotherapy. Since current treatments produce drug-induced unwanted toxicities and side effects, they require alternate therapies. A recent review article attempts to summarize the mechanistic perspective of melatonin in different cancer subtypes like skin cancer, breast cancer, hepatic cancer, renal cell cancer, non-small cell lung cancer (NSCLC), colon oral, neck, and head cancer. The various studies described in this review will give a firm basis for the future evolution of anticancer drugs.

Cite this record

Suman Lata Rohilla, Mahaveer Singh, Sakshi Priya, Waleed Hassan Almalki, Shahril Bin Mohamed Haniffa, Vetriselvan Subramaniyan, et al. (2022). Exploring the Mechanical Perspective of a New Anti-Tumor Agent: Melatonin. Journal of Environmental Pathology Toxicology and Oncology, 42(1), 1–16. https://doi.org/10.1615/jenvironpatholtoxicoloncol.2022042088

Copy in another style

Rohilla, S. L., Singh, M., Priya, S., Almalki, W. H., Haniffa, S. B. M., Subramaniyan, V., Fuloria, S., Fuloria, N. K., Sekar, M., & Singh, S. K. (2022). Exploring the Mechanical Perspective of a New Anti-Tumor Agent: Melatonin. Journal of Environmental Pathology Toxicology and Oncology, 42(1), 1–16. https://doi.org/10.1615/jenvironpatholtoxicoloncol.2022042088
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.